Dallas, TX -- (SBWire) -- 11/23/2010 -- SandlerResearch announce Epigenetics Therapeutics to 2017 – High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma

GBI Research’s report, “Epigenetics Therapeutics to 2017 – High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma”, provides in-depth analysis of trends, issues and challenges in this industry. The report analyzes the technology that shape the industry dynamics for the key geographies: the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Further, the report provides competitive benchmarking for the leading companies and analyzes the licensing agreements that shape the global markets.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope
The scope of this report includes:
Annualized market data from 2001 to 2009, forecast forward to 2016.
Analysis of the leading technology in this space
Market characterization
Key drivers and barriers that have a significant impact on the market.
Competitive benchmarking of leading companies.

Reasons to buy
The report will enhance your decision making capability. It will allow you to
Align your product portfolio to the markets with high growth potential.
Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth.
Reinforce R&D pipelines
Develop key strategic initiatives by understanding the key focus areas of leading companies.
Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps.

1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 GBI Research Report Guidance 7

3 Market Characterization: Global Epigenetics Market 8
3.1 Disease Overview 8
3.1.1 Myelodysplastic Syndrome 8
3.1.2 Cutaneous T-cell Lymphoma 8
3.2 Epigenetic Drugs 9
3.3 The US 11
3.4 Top Five European Markets 12
3.5 Japan 14

4 In-Depth Analysis 16
4.1 Introduction 16
4.2 Vidaza (Azacitidine) 16
4.2.1 Indication 16
4.2.2 Mechanism of Action 16
4.2.3 Revenue Forecast 16
4.2.4 Key Takeaway 23
4.2.5 Market Potential 23
4.2.6 Pipeline Analysis 29
4.2.7 Drug Profile 32
4.3 Dacogen (Decitabine) 33
4.3.1 Indication 33
4.3.2 Mechanism of action 33
4.3.3 Revenue Forecast 34
4.3.4 Key Takeaway 39
4.3.5 Market Potential 39
4.3.6 Pipeline Analysis 45
4.3.7 Drug Profile 48
4.4 Zolinza (Vorinostat) 49
4.4.1 Indication 49
4.4.2 Mechanism of Action 49
4.4.3 Revenue Forecast 49
4.4.4 Disease Overview 55
4.4.5 Market Potential 55
4.4.6 Pipeline Analysis 61
4.4.7 Drug Profile 63
4.5 Istodax (Romidepsin) 64
4.5.1 Indication 64
4.5.2 Disease Overview 64
4.5.3 Mechanism of Action 65
4.5.4 Market Potential 65
4.5.5 Pipeline Analysis 71
4.5.6 Clinical Studies by Phases 71
4.5.7 Clinical Studies by Indication 72
4.5.8 Drug Profile 73

5 Competitive Landscape 75
5.1 Merck & Co. 75
5.1.1 Company Overview 75
5.1.2 Business Description 75
5.1.3 SWOT 77
5.2 Celgene Corporation 77
5.2.1 Company Overview 77
5.2.2 Business Description 78
5.2.3 SWOT 79
5.3 EISAI 80
5.3.1 Company Overview 80
5.3.2 Business Description 80
5.3.3 SWOT 82

6 Epigenetic Therapeutics: Appendix 83
6.1 Market Definitions 83
6.2 Abbreviations 83
6.3 Research Methodology 84
6.3.1 Coverage 85
6.3.2 Secondary Research 85
6.3.3 Primary Research 85
6.3.4 Forecasts 86
6.3.5 Expert Panel Validation 88
6.4 Contact Us 88
6.5 Disclaimer 88
6.6 Sources 88

ABBREVIATIONS

Browse all : Pharmaceuticals Market
http://www.sandlerresearch.org/market-research/pharmaceuticals/

Browse all : GBI Research
http://www.sandlerresearch.org/publishers/gbi-research/

Browse all : Newly Published Market Research
http://www.sandlerresearch.org/LatestReport.aspx

Related Reports :

Stakeholder Insight: Non-Hodgkin's Lymphomas Diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL)
http://www.sandlerresearch.org/Reports/7267-stakeholder-insight-non-hodgkins-lymphomas-diffuse-large-b-cel.html

Multiple Myeloma Research Foundation (MMRF)-Detailed Product Pipeline
http://www.sandlerresearch.org/Reports/30269-multiple-myeloma-research-foundation-mmrf-detailed-product-pipe.html

The Leukemia & Lymphoma Society (LLS)-Detailed Product Pipeline
http://www.sandlerresearch.org/Reports/30923-the-leukemia-lymphoma-society-lls-detailed-product-pipeline.html

Pipeline Insight: Lymphomas, Multiple Myeloma & Myelodysplastic Syndromes - Optimization of clinical practice creates opportunities for emerging therapies
http://www.sandlerresearch.org/Reports/19740-pipeline-insight-lymphomas-multiple-myeloma-myelodysplastic-s.html

Pipeline Insight: Multiple Sclerosis - Risk-benefit ratio under the spotlight for potent pipeline drugs
http://www.sandlerresearch.org/Reports/7133-pipeline-insight-multiple-sclerosis-risk-benefit-ratio-under-t.html

About Sandler Research
Sandler Research houses a comprehensive online library of more than 10,000 reports, in-depth market research studies of 5000+ micro markets, and 25 industry specific websites. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe.

Our client list boasts of many eminent publishers of such reports from across the world. As a third-party reseller of market research reports, we employ various marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques, in order to generate better revenues for our clients, entailing positive and robust results.

We also provide 24/7 online and offline support to our customers

Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.sandlerresearch.org
Blog: http://sandlerresearch.blogspot.com/

Original Source : EPIGENETICS THERAPEUTICS MARKET
http://www.sandlerresearch.org/reports/33054-epigenetics-therapeutics-to-2017-high-market-potential-for-epig.html

Buy Now : Market Research
http://www.sandlerresearch.org/reports/15763-major-depressive-disorder-mdd-drug-pipeline-analysis-and-mark.html

Browse complete Report at : Epigenetics Therapeutics to 2017 – High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma

http://www.sandlerresearch.org/reports/33054-epigenetics-therapeutics-to-2017-high-market-potential-for-epig.html